Product Name | GS-441524 |
---|---|
Expiry Date | 1 Year From The Date Of Manufacture |
Storage Condition | Room Temperature |
CAS | 1191237-69-0 |
Function | Treatment For Cat FIP |
Dosage Form | Injection |
Country of Manufacture | China |
Packaging | 6ml/vial, 8ml/vial, 10ml/vial |
Strength | 20mg and 30mg |
GS-441524 is a nucleoside analog that acts as an alternative substrate and RNA-chain terminator for the viral RNA dependent RNA polymerase. It interjects itself in the chain reaction to prevent viral replication, stopping the spread of the virus to other cells and enabling the immune system to build a complete immune response. As the main metabolite of the antiviral prodrug remdesivir, it has a half-life of 24 hours in human patients.
For cats suffering from wet FIP (characterized by abnormal fluid accumulation in the abdomen or chest cavity), GS-441524 injection can rapidly reduce fluid build-up. In dry FIP cases (affecting internal organs like eyes, nervous system, or abdominal organs), the injection helps alleviate symptoms including neurological deficits, ocular inflammation, and organ-related dysfunctions.
Cats undergoing treatment often experience:
The injection is administered subcutaneously, allowing for relatively easy administration in home-based settings with proper training. Treatment protocols are highly individualized based on:
Treatment courses typically range from 8-12 weeks with regular veterinary check-ups, including blood tests and physical examinations to monitor response and adjust dosage as needed.